These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 29960017

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Oct; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M, Brand C, Louie J, Khan F.
    J Rehabil Med; 2016 Apr 28; 48(5):426-34. PubMed ID: 27097568
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, Hughes A.
    J Rehabil Med; 2010 Jan 28; 42(1):81-9. PubMed ID: 20111849
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB, Rosales RL, Dressler D.
    J Neural Transm (Vienna); 2009 Mar 28; 116(3):319-31. PubMed ID: 19142573
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM.
    J Neurol Neurosurg Psychiatry; 2000 Aug 28; 69(2):217-21. PubMed ID: 10896696
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G.
    Drug Saf; 2006 Aug 28; 29(1):31-48. PubMed ID: 16454533
    [Abstract] [Full Text] [Related]

  • 16. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Aug 28; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M, Kozlowski O, Froger J.
    J Neurol; 2002 Jan 28; 249(1):76-84. PubMed ID: 11954872
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J, Hoare B, Wallen M.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD003469. PubMed ID: 15495055
    [Abstract] [Full Text] [Related]

  • 20. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P, Mochizuki G, Dutta T, Richardson D, Brooks D.
    Occup Ther Int; 2016 Dec 18; 23(4):379-389. PubMed ID: 27696580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.